ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.620
-0.050 (-1.87%)
Dec 20, 2024, 4:00 PM EST - Market closed
ImmunityBio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,826 | 3,352 | 2,076 | 2,419 | - | - | |
| Market Cap Growth | 129.66% | 61.49% | -14.18% | - | - | - | |
| Enterprise Value | 2,714 | 3,882 | 2,676 | 2,681 | - | - | |
| Last Close Price | 2.62 | 5.02 | 5.07 | 6.08 | - | - | |
| PS Ratio | 243.47 | 5388.88 | 8648.47 | 2589.53 | - | - | |
| PB Ratio | -3.48 | -5.72 | -4.61 | -9.92 | - | - | |
| EV/Sales Ratio | 370.17 | 6241.20 | 11149.27 | 2870.55 | - | - | |
| Debt / Equity Ratio | -1.37 | -1.51 | -1.61 | -2.66 | -2.33 | -1.77 | |
| Asset Turnover | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| Quick Ratio | 2.22 | 4.63 | 0.22 | 0.86 | 1.44 | 2.00 | |
| Current Ratio | 2.68 | 5.05 | 0.28 | 0.91 | 1.64 | 2.10 | |
| Return on Assets (ROA) | -56.35% | -52.11% | -52.73% | -57.48% | -72.72% | -74.79% | |
| Return on Capital (ROIC) | -76.95% | -78.80% | -64.47% | -70.68% | -106.38% | -124.31% | |
| Earnings Yield | -32.20% | -17.40% | -20.07% | -14.34% | - | - | |
| FCF Yield | -23.78% | -11.85% | -20.03% | -12.73% | - | - | |
| Buyback Yield / Dilution | -54.09% | -27.19% | -2.74% | -3.23% | -2.93% | -13.36% | |
| Total Shareholder Return | -54.09% | -27.19% | -2.74% | -3.23% | -2.93% | -13.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.